A first-in-human phase 1 trial at UCI Health is using padeliporfin vascular-targeted photodynamic therapy to destroy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results